BACKGROUND: T cells are required for proper healing after myocardial infarction. The mechanism of their beneficial action, however, is unknown. The proinflammatory danger signal ATP, released from damaged cells, is degraded by the ectonucleotidases CD39 and CD73 to the anti-inflammatory mediator adenosine. Here, we investigate the contribution of CD73-derived adenosine produced by T cells to cardiac remodeling after ischemia/reperfusion and define its mechanism of action.
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arly reperfusion strategies after myocardial infarction (MI) have dramatically reduced mortality in patients with MI, but survivors remain at increased risk of developing heart failure. 1 The degree of functional impairment depends critically on the wound healing response and the subsequent process of ventricular remodeling. 2 Therefore, identification of effector cells and receptors involved in the regulation of inflammation and scar formation is likely to have a large biomedical impact.
Ischemia-induced death of cardiomyocytes elicits a sterile inflammatory response that serves to clear the injured heart of dead cells and matrix debris, followed by the replacement of damaged tissue with a stable scar. 2 Injured cardiomyocytes release damage-associated molecular patterns, leading to the activation of innate immunity, which instigates the further recruitment of leukocytes through the production of proinflammatory cytokines and chemokines. 2 Neutrophils are the first to infiltrate the heart, followed by monocytes and lymphocytes in the later phase. Cells of the innate immune system are largely responsible for the wound clearing necessary for the formation of highly vascularized granulation tissue. However, recent evidence suggests that CD4 + T cells also can influence the healing and scarring process. 3 In addition, CD4 + invariant natural killer T cells may contribute to inflammation after reperfusion, as shown for liver reperfusion injury. 4 In contrast with innate mechanisms in cardiac injury and repair, much less is known about the role of the adaptive immune system after MI. Recent reports have shown that T cells, especially T-helper (Th) cells and regulatory T cells, improve wound healing after MI.
5-7 CD4 + T cell-deficient mice subjected to MI show increased left ventricular dilatation, increased leukocytes, and a higher prevalence of proinflammatory monocytes. 5 Expansion of regulatory T cells in vivo by either adoptive transfer or CD28 superagonistic antibody improved cardiac function and attenuated fibrosis and proinflammatory cytokine expression. 6 CD28 superagonistic antibody-mediated regulatory T-cell expansion was associated with an M2-like macrophage differentiation, suggesting a beneficial influence on wound healing by modulating monocyte/macrophage differentiation. 7 Although these studies have clearly demonstrated the important role of T cells in cardiac remodeling, the mechanisms underlying the T cell-induced cardiac protection are still only poorly understood.
Extracellular nucleotides and nucleosides are well known to be important regulators in the inflammatory response. 8 ATP and NAD are released by necrotic tissue and activated immune cells through connexin43 and pannexin-1 hemichannels. 9 ,10 Extracellular ATP acts on P2 receptors and preferably triggers proinflammatory effects. 8 However, the half-life of extracellular nucleotides is extremely short and is determined by the activity of several ectoenzymes hydrolyzing ATP. CD39 is generally considered to be the most prominent ATP-degrading enzyme, 8 but ecto-nucleotide pyrophosphatase/ phosphodiesterases (ENPPs) have also been described that convert both ATP and NAD to AMP, the immediate precursor of adenosine. 11 AMP is further hydrolyzed by CD73 to adenosine, which in turn can activate different types of G protein-coupled adenosine receptors (ARs). 12 The A 1 R and A 3 R interact with G i and G o proteins, resulting in proinflammatory effects in a number of cells, although anti-inflammatory effects have also been described. 13 Both the A 2a R and A 2b R are known to be coupled to G s proteins linked to stimulation of adenylate cyclase and accumulation of cAMP, whereas A 2b R also can activate phospholipase C via G q 12 and may be regulated by additional binding partners.
14 Activation of the A 2a R induces potent anti-inflammatory effects, 15 but there are conflicting results on the role of the A 2b R in inflammation. 13 Adenosine signaling is terminated by enzymatic deamination to inosine or via cellular reuptake by equilibrative or concentrative nucleoside transporters with subsequent rephosphorylation to AMP. 16 The relative importance of the different metabolic pathways for the formation of AMP and adenosine is cur-
Clinical Perspective
What Is New?
• Lack of CD73 (AMP→adenosine) on T cells enhances tissue fibrosis and worsens myocardial function in the remodeling phase after myocardial infarction.
• The phenotypes of the immune cell (CD4-CD73 −/− ) and global CD73 knockouts are identical.
• T cells migrating into the injured heart upregulate their enzymatic machinery to enhance the extracellular degradation of ATP and NAD to adenosine.
• On activated T cells, degradation of nucleotides predominantly involves pyrophosphatases (ectonucleotide pyrophosphatase/phosphodiesterases 1 and 3), not CD39.
• T cells lacking CD73 show accelerated production of proinflammatory and profibrotic cytokines (interleukin-2, interferon-γ, interleukin-17).
• The A 2b receptor is upregulated on cardiac immune cells in the remodeling phase.
What Are the Clinical Implications?
• Local adenosine formation by CD73 on T cells is the body's own defense mechanism to critically control inflammation induced by myocardial infarction.
• This mechanism might be exploited to promote the healing/remodeling process by specifically targeting the A 2b receptor, which is the only adenosine receptor upregulated in the infarcted heart.
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rently not known. It also remains to be seen whether there is significant remodeling of purine metabolism and signaling during metabolic programming in stimulated T cells. 17 Global deficiency of CD73 was reported to severely impair cardiac function after ischemia/reperfusion (I/R), accompanied by a prolonged inflammatory response and enhanced fibrosis. 18 Because CD73 is expressed mainly on granulocytes and T cells after MI, 19 the present study explored the role of CD73 on T cells on the cardiac healing process and ventricular remodeling using newly generated CD4-CD73 −/− mice.
METHODS

Mouse Models
Animal experiments were performed in accordance with the national guidelines for animal care and were approved by the Landesamt für Natur-, Umwelt-und Verbraucherschutz. , and CD4-cre +/− mice (9-13 weeks of age) were bred at the Zentrale Einrichtung für Tierforschung und Tierschutzaufgaben. Details of the source of animals are given in Methods in the online-only Data Supplement.
Generation of Mice With CD4-Controlled Deletion of CD73
Mice homozygous for the floxed exon 2 CD73 allele (CD73 flox/ flox ) 20 were crossed with mice expressing Cre recombinase under the control of the CD4 promoter (CD4-Cre +/− ). Animals homozygous for floxed CD73 and hemizygous for Cre-recombinase were used as CD4-CD73 −/− mice, and mice homozygous for floxed CD73 and homozygous null for Cre-recombinase were used as controls. The primers used for genotyping are given in Methods in the online-only Data Supplement.
Infarct Model
Reperfused MI was induced as previously described. 18 In brief, mice were anaesthetized (isoflurane 1.5%), and the left anterior descending coronary artery was ligated for 50 minutes followed by reperfusion. Left anterior descending coronary artery occlusion was ensured by ST-segment elevation in ECG recordings.
Magnetic Resonance Imaging Experiments
Magnetic resonance imaging data were recorded on a 400-MHz Bruker AVANCE III 9.4-T wide-bore nuclear magnetic resonance spectrometer (Bruker, Rheinstetten, Germany) driven by ParaVision 5.1. Images were acquired with the Bruker Microimaging unit (Mini 0.5) equipped with a 30-mm birdcage resonator as recently described. 18 Regional ventricular wall movement analysis was performed with software developed in-house. In brief, local fractional shortening (FS) was calculated from individual short-axis slices. The left ventricle was then divided into 200 equally distributed sectors, and FS was calculated in each sector as the difference of end-diastolic and end-systolic radii divided by the end-diastolic value.
Polarized Light Microscopy
Hearts were embedded in Tissue-Tek (Sakura Finetec Inc, Torrance, CA) and cut into 8-μm sections from apex to base. Staining was performed with Picrosirius Red (Sigma Aldrich, St. Louis, MO), and polarized light microscopy (Olympus MX61 with BX polarizer) was used for quantification of collagen and collagen-type discrimination as recently described.
18
Cell Isolation, Flow Cytometry, and Cell Sorting Cardiac cells were isolated by a modified protocol previously described. 19 In brief, hearts were perfused according to the Langendorff method with an oxygenated saline medium for 5 minutes containing 30 mmol/L 2,3-butanedionmonoxime while initial perfusion pressure was maintained at 80 mm Hg. Hearts were digested by intracoronary delivery of NB 8 Broad Range collagenase solution (1.32 PZ U/ mL, SERVA Electrophoresis GmbH, Heidelberg, Germany) at 37°C until perfusion pressure was below ≈10 mm Hg. Heart tissue was mechanically disrupted, suspended in 2% BSA buffer, and gently dissociated by sequent pipetting steps. The cell suspension was first meshed through a 100-µm BD Falcon cell strainer and centrifuged at 55g to separate cardiomyocytes from noncardiomyocytes. Supernatant was again passed through a 40-µm mesh filter (BD Bioscience, Franklin Lake, NJ). Antibodies used for fluorescence-activated cell sorter analysis are listed in Methods in the onlineonly Data Supplement.
T-Cell Stimulation and Cytokine Measurements
For cytokine profiling of infiltrated cardiac T cells, CD3 + T cells were isolated from heart tissue of wild-type (WT) and CD4-CD73 −/− mice 7 days after I/R by cell sorting and stimulated with CD3 (5 µg/mL) and CD28 (8 µg/mL; both BD Pharming) antibodies overnight. Culture supernatants were subjected to Bioplex (BioRad, Hercules, CA) assay (mouse cytokine Th17 6-Plex and Singleplex Sets interleukin [IL]-2, IL-3, IL-4, IL-5, IL-13) to determine cytokine levels. Concentrations were normalized to 1000 T cells. For the analysis of cytokine release after A 2a R and A 2b R activation, CD4 + T cells were isolated from WT lymph nodes and cultured under stimulation conditions (3 µg/mL CD3 and 6 µg/mL CD28 antibodies) for 24 hours. 
Quantitative Real-Time Polymerase Chain Reaction
Quantitative real-time polymerase chain reaction was performed for mRNA expression analysis (target genes are listed in Table I in the online-only Data Supplement). Three days after I/R, T-cell subsets (3000 cells) were isolated from blood and heart by cell sorting (MoFlo XDP, Beckman-Coulter, Brea, CA). Preamplification was performed with the TaqMan PreAmp Cells-to-C T Kit (Life Technologies, Carlsbad, CA). Total RNA from granulocytes, antigen-presenting cells (APCs), cardiomyocytes, or lymph node T cells was isolated with the RNeasy Micro Kit (Qiagen, Hilden, Germany), and cDNA was generated with the QuantiTect Whole Transcriptome Kit (Qiagen) for granulocytes and APCs or the QuantiTect Reverse Transcription Kit (Qiagen) for lymph node T cells and cardiomyocytes.
Quantitative real-time polymerase chain reaction of T cells, granulocytes, and APCs from blood and heart was performed with preloaded TaqMan Array Microfluidic Cards and the ViiA 7 System (Applied Biosystems, Darmstadt, Germany 
High-Performance and Ultraperformance Liquid Chromatography Analysis of Nucleotide and Nucleoside Metabolism
A Hypersil BDS C18 column (250×4.6 mm; particle size, 3 µmol/L; Thermo Fisher Scientific, Langerwehe, Germany) was used as described. 22 For the measurement of nucleotide degradation in CD4 + T and CD8 + T cells from lymph nodes, ≈ 240 000 cells were incubated with 20 µmol/L ATP, cAMP, or etheno-NAD in Hank balanced salt solution (ATP, cAMP: 245 µL; etheno-NAD: 165 µL) at 37°C. Aliquots of the cell suspension (40-60 µL) were taken immediately after the addition of substrate and after 10, 30, and 60 minutes and directly centrifuged at 4°C for 2.5 minutes at 450g. Supernatants (ATP, cAMP: 50 µL; NAD: 32 µL) were applied to reverse-phase highperformance liquid chromatography. In the case of T cells isolated from blood and heart 3 days after I/R, ≈ 12 000 cells were incubated with 20 µmol/L etheno-AMP in 85 µL Hank balanced salt solution at 37°C, and aliquots (20 µL) were mixed with 50 µL precooled Hank balanced salt solution buffer. After centrifugation (4°C for 2.5 minutes at 450g), 65 µL supernatant was injected for high-performance liquid chromatography analysis. In the experiments with CD11b + myeloid cells, ≈50 000 cells were incubated with 20 µmol/L etheno-AMP, and the rate of degradation was measured in 1-µL samples subjected to ultraperformance liquid chromatography analysis. For ATP degradation in T cells from CD39 −/− mice, we used ≈ 60 000 cells in each assay and started the reaction with 150 µmol/L ATP to ensure saturating conditions over the time of measurement (60 minutes). Before the start of the reaction, cells were preincubated with the respective inhibitor for 10 minutes. Details of the chromatographic gradients used are given in Methods in the online-only Data Supplement.
The inhibitors used were 100 µmol/L POM1 (Tocris, Bristol, UK), 5 µmol/L PSB-POM144 (kindly provided by U. Kortz, Department of Life Sciences and Chemistry, Jacobs University Bremen, Germany), 1 mmol/L Levamisol (Sigma Aldrich, St. Louis, MO), and 2 µmol/L α-benzylamino-benzylphosphonic acid (Enamine, Monmouth Junction, NJ).
Statistics
Data are represented as mean±SD. Data were statistically analyzed by 1-way ANOVA, Mann-Whitney U test, or Student t test, depending on the outcome of the Shapiro-Wilk test of normality as stated in the figure legends. The threshold for statistical significance was set at P<0.05.
RESULTS
CD4-CD73 −/− Mice Show Impaired Healing After Myocardial I/R
To study the role of CD73 in adaptive immunity, we created a CD4-Cre×CD73flox mouse mutant (CD4-CD73) knockout. Because during T-cell development all T cells undergo a CD4 The study protocol was such that global and CD4-CD73 −/− mice were subjected to 50 minutes of I/R, and ventricular function was assessed by magnetic resonance imaging for a period of 4 weeks ( Figure 1A ). Compared with WT controls, ejection fraction of the heart was reduced already after 1 to 2 weeks after I/R, accompanied by significantly increased end-diastolic and end-systolic volumes ( Figure 1B Functional impairment was associated with enhanced tissue fibrosis within the infarct and border zone ORIGINAL RESEARCH ARTICLE of CD4-CD73 −/− mice ( Figure 1H ). Analysis of collagen by polarized light microscopy revealed predominantly thin and loosely assembled collagen III in CD4-CD73 −/− compared with the more organized collagen I in control animals ( Figure 1I ), resulting in a decrease in the ratio of collagen I to III. Again, changes in tissue fibrosis were identical in global CD73
−/− and CD4-CD73 −/− mutants.
Extracellular Nucleotide Metabolism on T Cells After Migration Into Injured Cardiac Tissue
Because the number of T cells in the injured heart is rather small, we assumed that the adenosine production by T cells was accelerated to elicit the functional effects possibly by metabolic reprogramming of extracellular purine catabolism during T-cell activation. We therefore carried out a comprehensive analysis of all genes potentially involved in the extracellular catabolism of ATP and NAD ( Figure 2A ) and compared respective expression levels in circulating T cells with those infiltrating the injured heart 3 days after myocardial I/R (for genes analyzed, see Table I in the online-only Data Supplement).
As shown in Figure 2B , connexin (Cx) 43, pannexin-1, and Cx37, known to release ATP and NAD, 10, 23 became upregulated on CD4 + T cells after infiltrating the heart. Note that Cx43 is not expressed on blood controls but became strongly upregulated within the injured heart. Similarly, the expression of adenosine deaminase and the equilibrative nucleoside transporter + T cells (data not shown). AMPase activity was increased 3-fold on T cells infiltrating the heart after MI ( Figure 2G ), which is similar to fluorescence-activated cell sorter data previously measured under identical experimental conditions. 19 AMP hydrolysis on cardiac T (Figure 2G) , suggesting a negligible contribution of alkaline phosphates or other AMP-degrading enzymes. To determine the relative importance of CD73 expressed on CD11b + cells to total adenosine formation, we measured CD73 activity on CD11b + cells isolated from the infarcted heart 3 days after MI. As shown in Figure V in the online-only Data Supplement, the rate of AMP degradation by CD11b + cells devoid of CD73 was not significantly different from that of the WT controls. Note, however, that AMPase activity of WT CD3 + T cells was ≈17 times higher compared with WT CD11b + controls and decreased by almost 70% in the respective CD73KO.
CD39 is generally considered to be the most prominent ATP-degrading enzyme. 8 We therefore assessed the contribution of CD39 to overall ATPase activity in naïve and stimulated CD4 + and CD8 + T cells. Quite unexpectedly, we found that total ATPase activity in stimulated CD4
+ or CD8 + cells isolated from WT and CD39 −/− mice was identical, whereas in naïve T cells, there was clear inhibition when CD39 was lacking ( Figure 3A) . Use of inhibitors for nucleoside triphosphate diphosphohydrolase 1 to 3 and ENPP1 (POM1, POM144 24 ), alkaline phosphatase (Levamisol), and acid prostate-specific phosphatase (benzylaminobenzylphosphonic acid) revealed that only POM144 strongly (80%) inhibited ATPase activity equally well in the absence and presence of CD39 ( Figure 3B ). Expression analysis revealed that ENPP1 was more highly expressed than CD39 ( Figure 3C ) in naïve and stimulated T cells. CD39 even became downregulated in stimulated cells, which is in line with only a minor role of CD39 in ATP degradation under these conditions. A similar conclusion can be drawn from expression analysis of various ATPases (nucleoside triphosphate diphosphohydrolases 1-8; ENPP1 and 3; alkaline phosphatase 2, 3, 6; prostatic acid phosphatase; and tartrate-resistant acid phosphatase) in CD4 + and CD8 + T cells from CD39 −/− mice, which showed persistent expression of ENPP1 in naïve and stimulated cells and downregulation of various other ATPases ( Figure 3D ). To address the differences in mRNA level between in vitro-stimulated and ex vivo-isolated T cells, we analyzed protein expression (fluorescence-activated cell sorter) of CD39 and ENPP1 on CD4 + and CD8 + T cells that were either in vitro stimulated or isolated from the heart and blood 7 days after MI. In contrast with the expression data ( Figure 3C and 3D) , we found both enzymes to be upregulated after T-cell activation ( Figure 3E and 3F ). This finding fits the increased ATPase activity of activated WT T cells, as shown in Figure 3A . It is likely that both enzymes participate in ATP hydrolysis in naïve T cells, whereas in the KO, ENPP1 can fully compensate for CD39 when this enzyme is lost in the KO.
Purinergic Signaling on Activated Cardiac T Cells
Because our data clearly demonstrate that there is an accelerated extracellular purine catabolism to adenosine via CD73, we wondered whether this was paralleled by respective changes in purine receptor subtype expression. Measurement of the mRNA expression pattern of the different adenosine receptors revealed that the A 2b R, not expressed on circulating blood T cells, became strongly upregulated at the mRNA level in T cells after migration to the injured myocardium ( Figure 4A and 4B). On the other hand, the mRNA expression of the A 2a R tended to be lower so that A 2a R and A 2b R were almost equally expressed. Upregulation of the A 2b R on transcript level was not limited to T cells but was also found in granulocytes (P=0.057) and APCs (P=0.029) compared with the respective controls ( Figure 4C and 4D). Cardiomyocytes, expressing mainly A 1 R mRNA, also significantly upregulated A 2b R mRNA after I/R, whereas the expression of the A 2a R transcript was significantly decreased ( Figure 4E ).
Lack of CD73 on T Cells Triggers the Formation of Proinflammatory and Profibrotic Cytokines Involving Both A 2a R and A 2b R
To identify the cytokines that are controlled by CD73 on cardiac T cells, we measured the cytokine production of T cells recovered from infarcted hearts in the absence or presence of CD73. To this end, T cells were isolated from WT and CD4-CD73 −/− hearts 7 days after I/R. As shown in Figure 5A , stimulated CD73 −/− T cells released significantly more proinflammatory and profibrotic cytokines IFN-γ and IL-17, respectively. Moreover, IL-2, IL-3, and IL-4 tended to be elevated when CD73 was lacking. In contrast, IL-6 release tended to be lower. The number of T cells infiltrating the injured heart To analyze the relative contribution of the A 2a R or A 2b R to the observed CD73-controlled changes on cytokine release ( Figure 5A ), we used stimulated CD4 + T cells from peripheral lymph nodes. T cells recovered from the injured heart were too small in number (≈200 cells per 1 mg heart tissue 18 ) for a systematic cytokine analysis. Similar to their tissue-infiltrating counterparts, in vitro-stimulated T cells again robustly upregulated the A 2b R on mRNA level, which was not measurably expressed on unstimulated cells ( Figure  VII in the online-only Data Supplement). Treatment of stimulated CD4 + T cells with the specific A 2a R (CGS-21680) agonists generally inhibited the production of measured cytokines ( Figure 5B ). CGS-21680 significantly decreased IL-2, IL-1b, tumor necrosis factor-α, and IL-10 by 57%, 13%, 71%, and 22%, respectively. It is interesting to note that those cytokines that showed an enhanced release by T cells lacking CD73 (IFN-γ, IL-17, IL-2 , and IL-3; Figure 5A ) were also inhibited by the A 2a R agonists ( Figure 5 ). To explore whether A 2b R on T cells confers proinflammatory or anti-inflammatory activity, we first used BAY 60-6583, a frequently used partial adenosine A 2b R receptor agonist. Because BAY 60-6583 has been reported to regulate superoxide production, 25 we first tested the 
. Gene expression of adenosine receptors on different cardiac immune cell subtypes and cardiomyocytes 3 days after ischemia/reperfusion (I/R).
Immune cell subsets were isolated from blood and heart 3 days after myocardial infarction (MI; A through D). Cardiomyocytes were isolated from the unstressed heart and 3 days after MI (E). mRNA expression was determined by quantitative real-time polymerase chain reaction. Gene expression was normalized to β-actin and TATA-box binding protein, only β-actin, or RPLP0. Statistical significance was determined by the Student t test or, in cases when the Shapiro-Wilk test of normality failed, by the Mann-Whitney rank-sum test. Values are mean±SD; n=3 to 5. ACPP indicates prostatic acid phosphatase; Akp, alkaline phosphatase; ENPP, ecto-nucleotide pyrophosphatase/phosphodiesterase; n.d., not detectable; NTPDases, nucleoside triphosphate diphosphohydrolase; and TRAP, tartrate-resistant acid phosphatase.*P<0.05. **P<0.01. ***P<0.001.
Figure 5. Cytokine release of cardiac T cells (A) and peripheral T cells treated with A 2a receptor (A 2a R) and A 2b receptor (A 2b R) agonists (B and C).
A, Cardiac CD3 + T cells were isolated from heart tissue of wild type (WT) and CD4-CD73 −/− mice 7 days after ischemia/reperfusion and stimulated overnight. Cytokines in the supernatant were measured by Bioplex assays, and concentrations were normalized to 1000 T cells. B, CD4 + T cells were isolated from lymph nodes of WT mice and stimulated for 24 hours in vitro. (Continued )
ORIGINAL RESEARCH ARTICLE effect of BAY 60-6583 on IFN-γ release from activated T cells isolated from A 2b R KO mice. It is surprising that we found that BAY 60-6583 over a wide dose range significantly inhibited IFN-γ release ( Figure VIII in the online-only Data Supplement). It is clear that the observed inhibitory effect is unrelated to A 2b R activation and reflects off-target effects. Therefore, we next used NECA, a high-affinity general adenosine receptor agonist, in the absence and presence of a specific A 2b R antagonist (PSB-603). As shown in Figure 5C , the inhibitory effect of NECA on IFN-γ release was antagonized by the A 2b R antagonist. We have also studied the influence of NECA response in T cells from A 2b R KO mice. Baseline IFN-γ release was not different between cells from WT (1500±752 pg/mL; n=9) and cells lacking the A 2b R (1362±746 pg/mL; n=10). As shown in Figure 5C , NECA decreased IFN-γ release, which, however, did not reach the level of significance (P=0.1189). The fact that T cells express little A 1 and no A 3 ( Figure 4A and 4B) might reflect the influence of NECA on the A 2a R. In the same experimental setting, we have found IL-6 production by activated T cells to be rather low (0.077±0.012 pg/mL; n=3). NECA stimulated IL-6 release ≈3-fold (0.26±0.052 pg/mL; n=3; P<0.01), and this effect was significantly inhibited by PSB-603 (0.16±0.026 pg/mL; n=3; P<0.05).
Because reports in the literature demonstrate that baseline adenosine levels may be high enough to produce some activation of the A 2b R, 26 we have carried out a series of controls and have measured the influence of 2 A 2b R antagonist (PSB-603 and MRS1754) on basal IFN-γ release from activated T cells. Neither of the inhibitors altered basal IFN-γ release ( Figure VIIIb in the online-only Data Supplement). Because our measurements were carried out in the presence of 2 U/mL adenosine deaminase and adenosine deaminase was reported to allosterically alter ligand binding to the A 2b R, 27 we also tested basal IFN-γ release over a wide concentration range of adenosine deaminase but found no effect in our system ( Figure 
DISCUSSION
This study demonstrates that T cells invading the injured heart undergo substantial purinergic metabolic reprogramming. They upregulate their enzymatic machinery for the accelerated hydrolysis of ATP, cAMP, and NAD to produce in a final step, via CD73, adenosine that by A 2a R and A 2b R inhibits in a feedback loop manner the formation of important proinflammatory (IFN-γ) and profibrotic (IL-17) cytokines. Thus, resolution of inflammation after MI importantly involves changes in extracellular purine metabolism on IL-17-secreting T cells and provides a compelling example of the importance of adenosine in adaptive immunity preventing adverse ventricular remodeling after MI.
T cells are a rather small cell population that infiltrate the heart only during the later phase after MI. 28 Despite being low in number, T cells are important regulators of the inflammatory and reparative responses by providing signals for macrophages or fibroblasts. 3, 29 Here, we demonstrate that T cell-mediated formation of IFN-γ, IL-17, IL-2, IL-3, and IL-4 is under the control of CD73-derived adenosine ( Figure 5 ). Thus, adenosineproducing T cells are in an important strategic position in orchestrating the resolution of inflammation and induction of tissue repair: IFN-γ mediates leukocyte attraction, activates macrophages, and induces chemokine secretion. 30 Reconstitution of mice lacking T cells with IFN-γ-negative CD4 + T cells results in decreased infarct size. 31 Moreover, IL-17 and IL-2 are toxic for cardiomyocytes, and deficiency of IL-17 improves cardiac healing. 32 IL-17 and IL-4 can also activate profibrotic pathways, stimulating fibroblast proliferation and profibrotic gene expression. 33 The extent of diastolic ventricular dilatation reported for mice lacking CD4 T cells 5 was similar to the hemodynamic changes observed in this study, again emphasizing the central role of T cellderived adenosine in the healing process. We recently have reported that deletion of CD73 does not alter the frequency of regulatory T cells 18 and that cardiomyocytes, platelets, CD31 − CD45
− cells (mostly fibroblasts), and endothelial cells show either no or very low expression of CD73. 19 The present study indicates that T-cell polarization is altered in CD73 −/− mice with a higher level of Th1 T cells (which secrete IFN-γ and IL-2) and Th17 cells, which are the predominant source of IL-17. Increased levels of Th1 and Th17 T cells are known to be involved in tissue destruction and are key mediators of autoimmunity. 34 In particular, IL-17 induces a positive feedback loop that perpetuates the primary immune response and sustains the proinflammatory milieu, resulting in excessive tissue destruction. These results can explain our previous observation that infarcted hearts of mice globally lacking CD73 display high neutrophil counts. We have previously reported that cardiac APCs and cardiac fibroblasts lack CD73, can degrade nucleotides only to the stage of AMP, and require CD73-expressing granulocytes and T cells for further degradation to adenosine. 18, 19 The present study shows that the global CD73 −/− and CD4-CD73 −/− mutants show an identical functional response to I/R, which rules out adenosineproducing granulocytes and places CD73 on T cells in a central metabolic position. Thus, T cells not only degrade the ATP and NAD released after activation but also hydrolyze AMP, reaching T cells by diffusion from local APCs and fibroblasts. In this view, T cells integrate the final conversion of AMP to adenosine. The functional consequence of this interesting metabolic cooperation is that, in return, T cell-derived adenosine may also act on surrounding cells in a paracrine fashion (Figure 6 ). Besides the well-characterized anti-inflammatory activity of the A 2a R demonstrated in many cellular systems, 12, 15 A 2b R stimulation was reported to suppress the release of proinflammatory tumor necrosis factor-α from neutrophils and macrophages, 35 to inhibit superoxide production in neutrophils, 36 to augment antiinflammatory IL-10 production in macrophages, 37 and to promote alternative (M2) macrophage activation. 38 An A 2a R-and A 2b R-mediated anti-inflammatory activity is in line with elevated tumor necrosis factor-α, reduced IL-10, and M1-driven macrophage phenotype in hearts of mice globally lacking CD73. 18, 19 Thus, critical events during the resolution of inflammation and induction of tissue repair appear to be adenosine controlled.
T-cell function is intimately linked to metabolic programs, which change on activation. 17 Our study shows that the microenvironment of the ischemic/necrotic heart importantly shapes the T-cell response by accelerating the rate of extracellular formation/degradation of purines. The T-cell hemichannels pannexin-1 and Cx43, known to release nucleotides, 9,10,39 were transcriptionally induced ( Figure 2B and 2C and Figure IVa ORIGINAL RESEARCH ARTICLE ating activation of various P2 receptors expressed on cardiac T cells. In the case of NAD, it reduces ADP ribosylation of the P2X7 receptors, 8, 40 which is likely to preserve T-cell function under conditions when more anti-inflammatory adenosine is formed.
Numerous studies support the concept that CD39 is the rate-limiting step in the degradation of extracellular ATP. 8 In the present study, we made the unexpected observation that ATPase activity of activated T cells remained unchanged when CD39 was genetically deleted. Expression studies of various ecto-ATPases and use of pharmacological inhibitors 24 indicate that most likely ENPP1 compensated for the loss of CD39 in activated T cells. Under normal circumstances, however, both CD39 and ENPP1 appear to participate in ATP hydolysis (Figure 3F) . Their fractional participation, however, is currently unclear. Note that compensation of CD39 ATPase activity by ENNP1 may not necessarily go along with similar functional changes. Although ENNP1 hydrolyzes ATP directly to AMP, CD39 involves ADP, which is known to be important, for example, in thrombus formation.
Ecto-pyrophosphatases are membrane-bound enzymes with reported Km in the micromolar range that catalyze the hydrolysis of extracellular ATP to AMP and inorganic pyrophosphate, but ENPP1 can also hydrolyze ATP into ADP and Pi, 11 which is consistent with the ATP breakdown products we measured. ENPP1 and ENPP3 are also important for the degradation of NAD 41, 42 and were found to be strongly upregulated on activated T cells in the present study. Together, our data show that the breakdown of ATP, cAMP, and NAD is dynamically regulated and converges in the formation of AMP involving, besides CD39, ENPP1 and ENPP3 under in vivo conditions. Although there are multiple sources of AMP, the critical bottleneck for the formation of adenosine is CD73, which is upregulated as well. 19 There are also different cellular sources for the formation of AMP: Monocytes and fibroblasts, both largely devoid of CD73, 19 express CD39 and can degrade ATP only to AMP, which may reach T cells by diffusion. 18 Because global CD73 −/− and CD4-CD73 −/− mice displayed an identical phenotype after MI, adenosine production by granulocytes, the only other CD73-expressing immune cell subpopulation in the injured heart, therefore appears to be less important.
Antigen-driven metabolic programming in T cells involves activation of the pentose phosphate pathway required for nucleotide biosynthesis and upregulation of transcription factors, including hypoxia-inducible factor-1α. 17 Here, we observed that activated T cells in vivo and in vitro strongly upregulate the expression of the A 2b R, which couples to G q and G i . 13 Upregulation of the A 2b R transcript appears not to be limited to T cells but was also observed on all immune cells infiltrating the injured heart, including cardiomyocytes. It is interesting to note that a hypoxia-responsive region on the promotor of the A 2b R has been identified, including a functional biding site for hypoxia-inducible factor, 43 which can explain our findings.
Deciphering the molecular networks that affect changes in lymphocyte metabolism after antigen recognition may aid in the development of therapeutic strategies. CD73 T cell-derived adenosine acting through A 2b R may be a novel target for limiting inflammation and scar formation after MI. Although activation of the A 2a R is well known to limit inflammation, 15 A 2b R activation yielded conflicting conclusions in a variety of systems. 13, 14 Here, we found a general downregulation of the A 2a R mRNA on activated T cells but a profound upregulation of the A 2b R transcript. Activation of A 2b R by the nonselective adenosine receptor agonist NECA inhibited proinflammatory IFN-γ production, which was antagonized by the potent A 2b R antagonist PSB-603. Similarly, PSB-603 significantly inhibited the NECA-induced release of IL-6, indicating that activation of A 2b R induces IL-6 formation also in T cells. Because it is well established that IL-6 is important for the polarization of naïve T cells to Th17 cells, there are several reasons to expect that A 2b R activation of myeloid cells, 44 fibroblasts, cardiac mesenchymal stem cells, 45 and T cells enhances IL-6 production and Th17 polarization after MI. This would imply a detrimental effect of A 2b R activation. However, treatment of the infarcted heart with the A 2b R agonist BAY 60-6583 significantly reduced infarct size, 21 which might include off-target effects, as shown in this study ( Figure VIIIa in the online-only Data Supplement). It is clear that there is a need for more specific A 2b R agonists to study in detail the role of A 2b R versus A 2a R signaling after MI. When the A 2b R is being considered as therapeutic target, it is essential to better understand the temporal changes of adenosine-induced IFN-γ inhibition and IL-6 stimulation after MI to decide at which point in time it may be beneficial to block or activate A 2b R. Various A 2b R agonists/antagonists have already been tested in the treatment of ventricular remodeling, yielding contradictory results that may relate to off-target effects or time when applied: either before 21 or at different times after infarction. 46, 47 As to the functional impact of the A 2b R, which requires micromolar adenosine concentrations for activation, it is conceivable that, under pathophysiological conditions, high levels of extracellular adenosine can be reached in the injured heart as a result of the hypoxic inhibition of adenosine uptake via adenosine kinase. 16 Because the A 2b R is likely to be activated only in an environment lacking oxygen, this feature could provide specificity in the therapy of the ischemic myocardium.
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